Skip to main content
SpringerLink
Log in

Neue Therapieoption bei Diabetes mellitus Typ 2

EMPA-REG-Studie

New therapy option for type 2 diabetes mellitus

EMPA-REG study

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Einhaltung ethischer Richtlinien

Interessenkonflikt. E. Windler und S. Nitschmann geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Präventive Medizin, Universitäres Herzzentrum Hamburg, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52 – Haus N36, 20246, Hamburg, Deutschland

    E. Windler

  2. Lippetal, Deutschland

    S. Nitschmann

Authors
  1. E. Windler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Windler.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Windler, E., Nitschmann, S. Neue Therapieoption bei Diabetes mellitus Typ 2. Internist 57, 102–104 (2016). https://doi.org/10.1007/s00108-015-3848-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-015-3848-z

Search

Navigation